AM1476 Granted Orphan Drug Designation in the US and EU for Treatment of Systemic Sclerosis 2024-02-05 Read more
Positive Phase I Data for its Phase II Ready Compound AM1476 for Treating Fibrosis 2023-05-23 Read more
